Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00452270
Status:
COMPLETED
Last Update Posted:
2007-05-03
First Post:
2007-03-26
Brief Title:
Decongestant Effect Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Double-Blind Randomized Parallel Group Placebo Controlled Study Evaluating the Decongestant Effect Time to Onset Duration of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold
Status:
COMPLETED
Status Verified Date:
2007-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to characterize the time profile of the decongestant properties of xylometazoline and to investigate its effect on sleep general well-being and smelltaste
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None